Advertisement

Index by author

January 01, 1984; Volume 25,Issue 1

A

  1. Abel, P W

    1. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
      K P Minneman and P W Abel
      Molecular Pharmacology January 1984, 25 (1) 56-63;

  2. Akaike, A

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
      G J Pascuzzo, A Akaike, M A Maleque, K P Shaw, R S Aronstam, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 92-101;
    2. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies.
      A Akaike, S R Ikeda, N Brookes, G J Pascuzzo, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 102-112;

  3. Albuquerque, E X

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
      G J Pascuzzo, A Akaike, M A Maleque, K P Shaw, R S Aronstam, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 92-101;
    2. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies.
      A Akaike, S R Ikeda, N Brookes, G J Pascuzzo, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 102-112;

  4. Aronstam, R S

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
      G J Pascuzzo, A Akaike, M A Maleque, K P Shaw, R S Aronstam, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 92-101;

  5. Audigier, Y

    1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
      E Castanas, P Giraud, Y Audigier, R Drissi, F Boudouresque, B Conte-Devolx and C Oliver
      Molecular Pharmacology January 1984, 25 (1) 38-45;

B

  1. Belinsky, S A

    1. Rates of allyl alcohol metabolism in periportal and pericentral regions of the liver lobule.
      S A Belinsky, T Matsumura, F C Kauffman and R G Thurman
      Molecular Pharmacology January 1984, 25 (1) 158-164;

  2. Boudouresque, F

    1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
      E Castanas, P Giraud, Y Audigier, R Drissi, F Boudouresque, B Conte-Devolx and C Oliver
      Molecular Pharmacology January 1984, 25 (1) 38-45;

  3. Bradley, R D

    1. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
      J W Lown, C C Hanstock, R D Bradley and D G Scraba
      Molecular Pharmacology January 1984, 25 (1) 178-184;

  4. Brattsand, R

    1. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
      E Dahlberg, A Thalén, R Brattsand, J A Gustafsson, U Johansson, K Roempke and T Saartok
      Molecular Pharmacology January 1984, 25 (1) 70-78;

  5. Brodersen, R

    1. Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis.
      B Honoré and R Brodersen
      Molecular Pharmacology January 1984, 25 (1) 137-150;

  6. Brookes, N

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies.
      A Akaike, S R Ikeda, N Brookes, G J Pascuzzo, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 102-112;

  7. Buckman, T D

    1. Proteases as probes of mitochondrial monoamine oxidase topography in situ.
      T D Buckman, M S Sutphin and S Eiduson
      Molecular Pharmacology January 1984, 25 (1) 165-170;

C

  1. Castanas, E

    1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
      E Castanas, P Giraud, Y Audigier, R Drissi, F Boudouresque, B Conte-Devolx and C Oliver
      Molecular Pharmacology January 1984, 25 (1) 38-45;

  2. Christie, J L

    1. Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      G M Rosen, E J Rauckman, S P Ellington, D C Dahlin, J L Christie and S D Nelson
      Molecular Pharmacology January 1984, 25 (1) 151-157;

  3. Conn, P M

    1. Biphasic regulation of the gonadotropin-releasing hormone receptor by receptor microaggregation and intracellular Ca2+ levels.
      P M Conn, D C Rogers and S G Seay
      Molecular Pharmacology January 1984, 25 (1) 51-55;

  4. Conte-Devolx, B

    1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
      E Castanas, P Giraud, Y Audigier, R Drissi, F Boudouresque, B Conte-Devolx and C Oliver
      Molecular Pharmacology January 1984, 25 (1) 38-45;

  5. Cragoe, E J

    1. Structure-activity relationships of amiloride and certain of its analogues in relation to the blockade of the Na+/H+ exchange system.
      P Vigne, C Frelin, E J Cragoe and M Lazdunski
      Molecular Pharmacology January 1984, 25 (1) 131-136;

D

  1. Dahlberg, E

    1. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
      E Dahlberg, A Thalén, R Brattsand, J A Gustafsson, U Johansson, K Roempke and T Saartok
      Molecular Pharmacology January 1984, 25 (1) 70-78;

  2. Dahlin, D C

    1. Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      G M Rosen, E J Rauckman, S P Ellington, D C Dahlin, J L Christie and S D Nelson
      Molecular Pharmacology January 1984, 25 (1) 151-157;

  3. Drissi, R

    1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
      E Castanas, P Giraud, Y Audigier, R Drissi, F Boudouresque, B Conte-Devolx and C Oliver
      Molecular Pharmacology January 1984, 25 (1) 38-45;

E

  1. Ehlert, F J

    1. Comparison of the muscarinic receptor binding activity of some tertiary amines and their quaternary ammonium analogues.
      F J Ehlert and D J Jenden
      Molecular Pharmacology January 1984, 25 (1) 46-50;

  2. Eiduson, S

    1. Proteases as probes of mitochondrial monoamine oxidase topography in situ.
      T D Buckman, M S Sutphin and S Eiduson
      Molecular Pharmacology January 1984, 25 (1) 165-170;

  3. Ellington, S P

    1. Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      G M Rosen, E J Rauckman, S P Ellington, D C Dahlin, J L Christie and S D Nelson
      Molecular Pharmacology January 1984, 25 (1) 151-157;

F

  1. Fain, J N

    1. Alpha 1-adrenergic stimulation of phosphatidylinositol turnover and respiration of brown fat cells.
      N Mohell, M Wallace and J N Fain
      Molecular Pharmacology January 1984, 25 (1) 64-69;

  2. Frelin, C

    1. Structure-activity relationships of amiloride and certain of its analogues in relation to the blockade of the Na+/H+ exchange system.
      P Vigne, C Frelin, E J Cragoe and M Lazdunski
      Molecular Pharmacology January 1984, 25 (1) 131-136;

G

  1. Giraud, P

    1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
      E Castanas, P Giraud, Y Audigier, R Drissi, F Boudouresque, B Conte-Devolx and C Oliver
      Molecular Pharmacology January 1984, 25 (1) 38-45;

  2. Goldman, M E

    1. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors.
      M E Goldman and J W Kebabian
      Molecular Pharmacology January 1984, 25 (1) 18-23;

  3. Goldstein, J A

    1. Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cytochrome P-450 in extrahepatic versus hepatic tissues.
      J A Goldstein and P Linko
      Molecular Pharmacology January 1984, 25 (1) 185-191;

  4. Gustafsson, J A

    1. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
      E Dahlberg, A Thalén, R Brattsand, J A Gustafsson, U Johansson, K Roempke and T Saartok
      Molecular Pharmacology January 1984, 25 (1) 70-78;

H

  1. Hanstock, C C

    1. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
      J W Lown, C C Hanstock, R D Bradley and D G Scraba
      Molecular Pharmacology January 1984, 25 (1) 178-184;

  2. Henry, J P

    1. Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding.
      D Scherman and J P Henry
      Molecular Pharmacology January 1984, 25 (1) 113-122;

  3. Honoré, B

    1. Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis.
      B Honoré and R Brodersen
      Molecular Pharmacology January 1984, 25 (1) 137-150;

I

  1. Ikeda, S R

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies.
      A Akaike, S R Ikeda, N Brookes, G J Pascuzzo, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 102-112;

J

  1. Jenden, D J

    1. Comparison of the muscarinic receptor binding activity of some tertiary amines and their quaternary ammonium analogues.
      F J Ehlert and D J Jenden
      Molecular Pharmacology January 1984, 25 (1) 46-50;

  2. Johansson, U

    1. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
      E Dahlberg, A Thalén, R Brattsand, J A Gustafsson, U Johansson, K Roempke and T Saartok
      Molecular Pharmacology January 1984, 25 (1) 70-78;

K

  1. Kauffman, F C

    1. Rates of allyl alcohol metabolism in periportal and pericentral regions of the liver lobule.
      S A Belinsky, T Matsumura, F C Kauffman and R G Thurman
      Molecular Pharmacology January 1984, 25 (1) 158-164;

  2. Kebabian, J W

    1. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors.
      M E Goldman and J W Kebabian
      Molecular Pharmacology January 1984, 25 (1) 18-23;

L

  1. Lazdunski, M

    1. Structure-activity relationships of amiloride and certain of its analogues in relation to the blockade of the Na+/H+ exchange system.
      P Vigne, C Frelin, E J Cragoe and M Lazdunski
      Molecular Pharmacology January 1984, 25 (1) 131-136;

  2. Linko, P

    1. Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cytochrome P-450 in extrahepatic versus hepatic tissues.
      J A Goldstein and P Linko
      Molecular Pharmacology January 1984, 25 (1) 185-191;

  3. Lown, J W

    1. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
      J W Lown, C C Hanstock, R D Bradley and D G Scraba
      Molecular Pharmacology January 1984, 25 (1) 178-184;

M

  1. Mahan, L C

    1. The kinetics of competitive radioligand binding predicted by the law of mass action.
      H J Motulsky and L C Mahan
      Molecular Pharmacology January 1984, 25 (1) 1-9;

  2. Maleque, M A

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
      G J Pascuzzo, A Akaike, M A Maleque, K P Shaw, R S Aronstam, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 92-101;

  3. Matsumura, T

    1. Rates of allyl alcohol metabolism in periportal and pericentral regions of the liver lobule.
      S A Belinsky, T Matsumura, F C Kauffman and R G Thurman
      Molecular Pharmacology January 1984, 25 (1) 158-164;

  4. Matubayasi, N

    1. Membrane expansion and inhalation anesthetics. Mean excess volume hypothesis.
      T Mori, N Matubayasi and I Ueda
      Molecular Pharmacology January 1984, 25 (1) 123-130;

  5. Mellon, W S

    1. Specificity of dye-ligand interaction with the polynucleotide binding domain of 1,25-dihydroxyvitamin D3-receptor complexes of chicken intestinal cytosol.
      W S Mellon
      Molecular Pharmacology January 1984, 25 (1) 86-91;
    2. Dye-ligand interactions with 1,25-dihydroxyvitamin D3-receptor complexes from chicken intestine.
      W S Mellon
      Molecular Pharmacology January 1984, 25 (1) 79-85;

  6. Minneman, K P

    1. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
      K P Minneman and P W Abel
      Molecular Pharmacology January 1984, 25 (1) 56-63;

  7. Mohell, N

    1. Alpha 1-adrenergic stimulation of phosphatidylinositol turnover and respiration of brown fat cells.
      N Mohell, M Wallace and J N Fain
      Molecular Pharmacology January 1984, 25 (1) 64-69;

  8. Mori, T

    1. Membrane expansion and inhalation anesthetics. Mean excess volume hypothesis.
      T Mori, N Matubayasi and I Ueda
      Molecular Pharmacology January 1984, 25 (1) 123-130;

  9. Motulsky, H J

    1. The kinetics of competitive radioligand binding predicted by the law of mass action.
      H J Motulsky and L C Mahan
      Molecular Pharmacology January 1984, 25 (1) 1-9;

N

  1. Neff, N H

    1. gamma-aminobutyric acid B receptors are negatively coupled to adenylate cyclase in brain, and in the cerebellum these receptors may be associated with granule cells.
      W J Wojcik and N H Neff
      Molecular Pharmacology January 1984, 25 (1) 24-28;

  2. Nelson, S D

    1. Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      G M Rosen, E J Rauckman, S P Ellington, D C Dahlin, J L Christie and S D Nelson
      Molecular Pharmacology January 1984, 25 (1) 151-157;

  3. Nishimura, S L

    1. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
      S L Nishimura, L D Recht and G W Pasternak
      Molecular Pharmacology January 1984, 25 (1) 29-37;

O

  1. Oliver, C

    1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
      E Castanas, P Giraud, Y Audigier, R Drissi, F Boudouresque, B Conte-Devolx and C Oliver
      Molecular Pharmacology January 1984, 25 (1) 38-45;

P

  1. Pascuzzo, G J

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
      G J Pascuzzo, A Akaike, M A Maleque, K P Shaw, R S Aronstam, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 92-101;
    2. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies.
      A Akaike, S R Ikeda, N Brookes, G J Pascuzzo, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 102-112;

  2. Pasternak, G W

    1. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
      S L Nishimura, L D Recht and G W Pasternak
      Molecular Pharmacology January 1984, 25 (1) 29-37;

R

  1. Rauckman, E J

    1. Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      G M Rosen, E J Rauckman, S P Ellington, D C Dahlin, J L Christie and S D Nelson
      Molecular Pharmacology January 1984, 25 (1) 151-157;

  2. Recht, L D

    1. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
      S L Nishimura, L D Recht and G W Pasternak
      Molecular Pharmacology January 1984, 25 (1) 29-37;

  3. Rickett, D L

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
      G J Pascuzzo, A Akaike, M A Maleque, K P Shaw, R S Aronstam, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 92-101;
    2. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies.
      A Akaike, S R Ikeda, N Brookes, G J Pascuzzo, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 102-112;

  4. Roempke, K

    1. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
      E Dahlberg, A Thalén, R Brattsand, J A Gustafsson, U Johansson, K Roempke and T Saartok
      Molecular Pharmacology January 1984, 25 (1) 70-78;

  5. Rogers, D C

    1. Biphasic regulation of the gonadotropin-releasing hormone receptor by receptor microaggregation and intracellular Ca2+ levels.
      P M Conn, D C Rogers and S G Seay
      Molecular Pharmacology January 1984, 25 (1) 51-55;

  6. Rosen, G M

    1. Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
      G M Rosen, E J Rauckman, S P Ellington, D C Dahlin, J L Christie and S D Nelson
      Molecular Pharmacology January 1984, 25 (1) 151-157;

S

  1. Saartok, T

    1. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
      E Dahlberg, A Thalén, R Brattsand, J A Gustafsson, U Johansson, K Roempke and T Saartok
      Molecular Pharmacology January 1984, 25 (1) 70-78;

  2. Scherman, D

    1. Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding.
      D Scherman and J P Henry
      Molecular Pharmacology January 1984, 25 (1) 113-122;

  3. Scraba, D G

    1. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
      J W Lown, C C Hanstock, R D Bradley and D G Scraba
      Molecular Pharmacology January 1984, 25 (1) 178-184;

  4. Seay, S G

    1. Biphasic regulation of the gonadotropin-releasing hormone receptor by receptor microaggregation and intracellular Ca2+ levels.
      P M Conn, D C Rogers and S G Seay
      Molecular Pharmacology January 1984, 25 (1) 51-55;

  5. Seeman, P

    1. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
      K A Wreggett and P Seeman
      Molecular Pharmacology January 1984, 25 (1) 10-17;

  6. Shaw, K P

    1. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
      G J Pascuzzo, A Akaike, M A Maleque, K P Shaw, R S Aronstam, D L Rickett and E X Albuquerque
      Molecular Pharmacology January 1984, 25 (1) 92-101;

  7. Sutphin, M S

    1. Proteases as probes of mitochondrial monoamine oxidase topography in situ.
      T D Buckman, M S Sutphin and S Eiduson
      Molecular Pharmacology January 1984, 25 (1) 165-170;

T

  1. Thalén, A

    1. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
      E Dahlberg, A Thalén, R Brattsand, J A Gustafsson, U Johansson, K Roempke and T Saartok
      Molecular Pharmacology January 1984, 25 (1) 70-78;

  2. Thurman, R G

    1. Rates of allyl alcohol metabolism in periportal and pericentral regions of the liver lobule.
      S A Belinsky, T Matsumura, F C Kauffman and R G Thurman
      Molecular Pharmacology January 1984, 25 (1) 158-164;

U

  1. Ueda, I

    1. Membrane expansion and inhalation anesthetics. Mean excess volume hypothesis.
      T Mori, N Matubayasi and I Ueda
      Molecular Pharmacology January 1984, 25 (1) 123-130;

V

  1. Vigne, P

    1. Structure-activity relationships of amiloride and certain of its analogues in relation to the blockade of the Na+/H+ exchange system.
      P Vigne, C Frelin, E J Cragoe and M Lazdunski
      Molecular Pharmacology January 1984, 25 (1) 131-136;

W

  1. Wallace, M

    1. Alpha 1-adrenergic stimulation of phosphatidylinositol turnover and respiration of brown fat cells.
      N Mohell, M Wallace and J N Fain
      Molecular Pharmacology January 1984, 25 (1) 64-69;

  2. Washtien, W L

    1. Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil.
      W L Washtien
      Molecular Pharmacology January 1984, 25 (1) 171-177;

  3. Wojcik, W J

    1. gamma-aminobutyric acid B receptors are negatively coupled to adenylate cyclase in brain, and in the cerebellum these receptors may be associated with granule cells.
      W J Wojcik and N H Neff
      Molecular Pharmacology January 1984, 25 (1) 24-28;

  4. Wreggett, K A

    1. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
      K A Wreggett and P Seeman
      Molecular Pharmacology January 1984, 25 (1) 10-17;
Back to top

In this issue

Advertisement